Sales and Marketing

Showing 15 posts of 11527 posts found.

Takeda: we’re working on Ebola too

November 24, 2014 Research and Development, Sales and Marketing Ebola, GSK, Gates, Obama, WHO, brett wells, pharmafile, rajeev, vaccines, venkaya, venkayya

The president of Takeda Vaccines has told Pharmafile that the Japanese firm has identified compounds that could help prevent infection …

Antibiotics: will the industry saviour please stand up

November 24, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Antibiotics, EAA, MRC, WHO, resistance, susie lunt

The spectre of a new ‘dark ages’ for humanity where common infections begin to kill again is increasingly making itself …

New managing director for Napp Pharmaceuticals

November 24, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Napp, alberto, martinez

Alberto Martinez has joined Napp Pharmaceuticals in the UK as its new managing director, taking over the role from Dietmar …

ABPI: NHS must change to allow stratified drugs

November 21, 2014 Research and Development, Sales and Marketing ABPI, NHS, george freeman, personalised, rawal, stratified medicines

The development of stratified medicines – especially in therapy areas outside of oncology – will have a significant effect on …

Ablynx looks to GSK for new chief commercial officer

November 21, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ablynx, johan heylan

Belgium-based biopharma firm Ablynx has appointed Johan Heylen to be its chief commercial officer and assume responsibility for all commercial …

Global drug spending set to top $1 trillion

November 20, 2014 Sales and Marketing Gilead, IMS, Kadcyla, Perjeta, drugs, hepatitis C, sovaldi, spend

Worldwide spending on drugs will reach over $1 trillion in 2014 and $1.3 trillion by 2018, according to a new …

Gilead gets Harvoni boost for Europe

November 20, 2014 Sales and Marketing EU, Gilead, HCV, harvoni, hepc, ledipasvir, sofosbuvir, svaldi

Gilead Sciences’ new hepatitis C (HCV) tablet Harvoni has been approved across the European Union to treat the majority of …

Sanofi showcases alirocumab at AHA

November 20, 2014 Sales and Marketing Amgen, PCSK9, Regeneron, Sanofi, aha, alirocumab, evolocumab

Sanofi and Regeneron released a battery of new Phase III data on their PCSK9 inhibitor alirocumab this week, reinforcing the …

NICE aims for earlier cancer diagnosis

November 20, 2014 Sales and Marketing Cancer, England, NHS, NICE, OECD, UK, baker

NICE is updating its guidance in a bid to help doctors spot the signs and symptoms of cancer as part …

Sanofi names new board member

November 20, 2014 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Sanofi, bonnie bassler

Sanofi has appointed Professor Bonnie Bassler as an independent member to sit among its board of directors. Bassler has more …

GSK tests mHealth trial solutions

November 19, 2014 Medical Communications, Sales and Marketing Apple, GSK, Medidata, dr Vries, healthpatch, mhealth

GlaxoSmithKline is experimenting with mobile health (mHealth) devices linked to cloud services in clinical trials as part of a bid …

AZ predicts strong growth ahead of Pfizer deadline

November 19, 2014 Sales and Marketing AZD9291, AstraZeneca, Pfizer, Soriot, definiens

AstraZeneca has announced that it expects to deliver revenues of over $45 billion by 2023 as it makes its final …

Reckitt finalises pharmaceutical demerger plans

November 19, 2014 Business Services, Sales and Marketing Reckitt Benckiser Pharmaceuticals, cillit bang, indivior, suboxone

Reckitt Benckiser has confirmed its plans to spin-off its pharmaceutical portfolio from its core consumer products business. Final details of …

Europe must prepare for COPD ‘timebomb’

November 19, 2014 Sales and Marketing COPD, Europe, European COPD Coalition, Spiriva, asthma, chronic obstructive pulmonary disease

Health services in Europe are not making sufficient effort to cope with the escalating burden of chronic obstructive pulmonary disease …

NICE wants more Xolair data

November 19, 2014 Sales and Marketing Genentech, NHS, NICE, Novartis, UK, Xolair, hives, omalizumab

 Novartis has been asked in draft guidance to give NICE more information before the watchdog can recommend its veteran asthma …
The Gateway to Local Adoption Series

Latest content